Diffuse astrocytoma IDH-1 mutant

Case contributed by Bruno Di Muzio
Diagnosis certain


Syncopal episodes.

Patient Data

Age: 30 years

MRI Brain


The lesion in the left medial cranial fossa has broad contact with the cranial vault, but there is no reaction the adjacent bone and no meningeal enhancement. There is no evidence of cortex or CSF cleft between the lesion and deep white matter, confirming intra-axial site. There is no contrast enhancement. There is no diffusion restriction. Cerebral parenchymal signal intensity and architecture are elsewhere normal. There is no hydrocephalus.

There is abnormal signal within the left globe consistent with silicon oil injection for the treatment of prior retinal detachment.

Conclusion: The tumor is almost certainly a diffuse astrocytoma IDH+ve and unlikely to have 1p19q deletion given prominent partial flair suppression. An outside possibility is a large DNET although this is much less likely.


Sections show a moderately cellular tumor composed of moderately pleomorphic cells containing round to oval, hyperchromatic, vesicular nuclei with inconspicuous nucleoli. Tumor cells are arranged in diffuse sheets with microcyst formation. Tumor cells demonstrate perineuronal satellitosis and subpial aggregation.
Occasional mitotic figures are identified (up to 1/1ohpf). No necrosis or microvascular proliferation is seen.


  • GFAP: Positive

  • NogoA: Positive

  • Nestin: Positive (intermediate)

  • IDH-l R132H: Positive (mutated)

  • ATRX: Negative (mutated)

  • p53: Positive

  • p16: Negative

  • Topoisomerase labeling index: Approximately 5%.

Final diagnosis

diffuse astrocytoma, IDH-l mutant (WHO Grade 2).

Case Discussion

The imaging appearances of this left temporal lobe tumor are those of a low-grade glioma, with typical features of what used to be called protoplasmic astrocytoma before the 2016 update on the WHO classification of CNS tumors, a subtype of diffuse astrocytomas that is no longer recognized as a distinct entity.

This case has been confirmed as an astrocytic tumor IDH-1 mutated and ATRX mutated, making the final diagnosis of a diffuse astrocytoma IDH-1 mutant. Remember that ATRX loss/mutation and 1p19q co-deletion are essentially mutually exclusive, which means that ATRX mutated = no 1p19q co-deletion.  

How to use cases

You can use Radiopaedia cases in a variety of ways to help you learn and teach.

Creating your own cases is easy.

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.